ATE256461T1 - Benutzung von comt-inhibitoren als analgetika - Google Patents

Benutzung von comt-inhibitoren als analgetika

Info

Publication number
ATE256461T1
ATE256461T1 AT01919513T AT01919513T ATE256461T1 AT E256461 T1 ATE256461 T1 AT E256461T1 AT 01919513 T AT01919513 T AT 01919513T AT 01919513 T AT01919513 T AT 01919513T AT E256461 T1 ATE256461 T1 AT E256461T1
Authority
AT
Austria
Prior art keywords
analgesics
comt inhibitors
comt
inhibitors
pain
Prior art date
Application number
AT01919513T
Other languages
English (en)
Inventor
Paeivi Aho
Inge-Britt Linden
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Application granted granted Critical
Publication of ATE256461T1 publication Critical patent/ATE256461T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT01919513T 2000-03-17 2001-03-16 Benutzung von comt-inhibitoren als analgetika ATE256461T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20000635A FI20000635A0 (fi) 2000-03-17 2000-03-17 COMT-inhibiittoreiden käyttö analgeettina
PCT/FI2001/000265 WO2001068083A1 (en) 2000-03-17 2001-03-16 Use of comt inhibitors as analgesics

Publications (1)

Publication Number Publication Date
ATE256461T1 true ATE256461T1 (de) 2004-01-15

Family

ID=8557970

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01919513T ATE256461T1 (de) 2000-03-17 2001-03-16 Benutzung von comt-inhibitoren als analgetika

Country Status (9)

Country Link
US (1) US6723754B2 (de)
EP (1) EP1263425B1 (de)
JP (1) JP4874489B2 (de)
AT (1) ATE256461T1 (de)
AU (1) AU2001246600A1 (de)
CA (1) CA2403352C (de)
DE (1) DE60101559T2 (de)
FI (1) FI20000635A0 (de)
WO (1) WO2001068083A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2484780A1 (de) * 2004-07-23 2012-08-08 The University of North Carolina At Chapel Hill Verfahren und Materialien zur Bestimmung der Schmerzempfindlichkeit und Vorhersage und Behandlung zugehöriger Störungen
MY148644A (en) * 2005-07-18 2013-05-15 Orion Corp New pharmaceutical compounds
AU2006272978B2 (en) 2005-07-26 2012-06-07 Bial - Portela & Ca, S.A. Nitrocatechol derivatives as COMT inhibitors
EP1845097A1 (de) 2006-04-10 2007-10-17 Portela & Ca., S.A. Oxadiazolderivate als COMT Inihibitoren
CA2572004A1 (en) * 2006-12-08 2008-06-08 Bernard Charles Sherman Tablets comprising entacapone and crospovidone
CN101631548B (zh) 2007-01-31 2014-08-27 比艾尔-坡特拉有限公司 Comt抑制剂的单次药物剂量单元和药物组合物
AU2009226221A1 (en) 2008-03-17 2009-09-24 Bial - Portela & Ca., S.A. Crystal forms of 5- [3- (2, 5-dichloro-4, 6-dimethyl-1-oxy-pyridine-3-yl) [1,2,3] oxadiazol-5-yl] -3-nit robenzene-1, 2-diol
KR102023255B1 (ko) 2009-04-01 2019-09-19 바이알 - 포르텔라 앤드 씨에이 에스에이 니트로카테콜 유도체를 포함하는 제약 제제 및 그의 제조 방법
US20140045900A1 (en) 2011-02-11 2014-02-13 Bial-Portela & Ca, S.A. Administration regime for nitrocatechols
BR112014014341A2 (pt) 2011-12-13 2017-08-22 Bial Portela & Ca Sa Intermediário metilado, seu método de preparação e seus usos, e composição farmacêutica
TWI638802B (zh) 2012-05-24 2018-10-21 芬蘭商奧利安公司 兒茶酚ｏ－甲基轉移酶活性抑制化合物
WO2016083863A1 (en) 2014-11-28 2016-06-02 Bial - Portela & Ca, S.A. Medicaments for slowing parkinson's disease
CN112533894A (zh) 2018-07-25 2021-03-19 奥赖恩公司 4,5-二羟基-2-(4-甲基苄基)异邻苯二甲腈溶剂化物及其结晶形式
US20220002232A1 (en) 2018-11-09 2022-01-06 Orion Corporation Process for the preparation of 4,5-dihydroxy-2-(4-methylbenzyl)isophthalonitrile
WO2022158991A1 (en) 2021-01-20 2022-07-28 Bial-Portela & Ca., S.A. Treatment of pain associated with parkinson's disease with opicapone in combination with levodopa

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB898879A (en) 1959-10-16 1962-06-14 Smith & Nephew Hydrazine derivatives
US5236952A (en) 1986-03-11 1993-08-17 Hoffmann-La Roche Inc. Catechol derivatives
DK175069B1 (da) * 1986-03-11 2004-05-24 Hoffmann La Roche Pyrocatecholderivater
US5283352A (en) 1986-11-28 1994-02-01 Orion-Yhtyma Oy Pharmacologically active compounds, methods for the preparation thereof and compositions containing the same
FI864875A0 (fi) 1986-11-28 1986-11-28 Orion Yhtymae Oy Nya farmakologiskt aktiva foereningar, dessa innehaollande kompositioner samt foerfarande och mellanprodukter foer anvaendning vid framstaellning av dessa.
YU213587A (en) * 1986-11-28 1989-06-30 Orion Yhtymae Oy Process for obtaining new pharmacologic active cateholic derivatives
US5489614A (en) * 1987-11-27 1996-02-06 Orion-Yhtyma Oy Catechol derivatives, their physiologically acceptable salts, esters and use
MTP1031B (en) * 1987-12-24 1990-10-04 Orion Yhtymae Oy New use of cathecol-o-methyl transferase (comt) inhibitors and their physiologically acceptable salts and esters
US5470737A (en) * 1993-06-09 1995-11-28 Mayo Foundation For Medical Education And Research Stably-transformed cells expressing human thiopurine methyltransferase
GB9510481D0 (en) 1995-05-24 1995-07-19 Orion Yhtymae Oy New catechol derivatives
GB9626472D0 (en) 1996-12-20 1997-02-05 Aperia Anita C New use of comt inhibitors
US6169103B1 (en) 1998-03-03 2001-01-02 Warner-Lambert Fluorine-substituted biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases
US6599530B2 (en) * 1998-09-14 2003-07-29 Orion Corporation Oral compacted composition comprising catechol derivatives

Also Published As

Publication number Publication date
FI20000635A0 (fi) 2000-03-17
US20030069316A1 (en) 2003-04-10
AU2001246600A1 (en) 2001-09-24
WO2001068083A1 (en) 2001-09-20
CA2403352C (en) 2009-05-05
US6723754B2 (en) 2004-04-20
DE60101559T2 (de) 2004-09-16
DE60101559D1 (de) 2004-01-29
CA2403352A1 (en) 2001-09-20
JP2003526663A (ja) 2003-09-09
EP1263425B1 (de) 2003-12-17
JP4874489B2 (ja) 2012-02-15
EP1263425A1 (de) 2002-12-11

Similar Documents

Publication Publication Date Title
DE60141230D1 (de) Verwendung von Botulinum Toxin zur Behandlung von neuralgischen Schmerzen
DE60101559D1 (de) Benutzung von comt-inhibitoren als analgetika
DE60011100D1 (de) Als cox-hemmer verwendbare sulfonylphenylpyrazol-verbindungen
ATE323661T1 (de) Behandlung von mineralischen stoffen
ATE468137T1 (de) Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten
TR200200204T2 (tr) MEK inhibitörleri kullanılarak kronik ağrının tedavi edilmesi.
PT1242410E (pt) Compostos novos
TR200200169T2 (tr) IL-18 inhibitörlerinin kullanımı.
EP1441761A4 (de) Verfahren zur prävention und behandlung von infektionen mit dem flavivirus bei tieren
DE50105735D1 (de) Chlorzoxazon zur behandlung von psoriasis
DE60128009D1 (de) Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
DE60112148D1 (de) Verwendung von (Per)fluoroetherverbindungen als Zusatzstoffe in Formulierungen zur Holzbehandlung
DK1274426T3 (da) Anvendelse af thioamidoxazolidinoner til behandling af knogleresorption og osteoporose
GB9626472D0 (en) New use of comt inhibitors
DE69930844D1 (de) Inhibitoren von mycobakterien
DE69904297D1 (de) Neue verwendung von ropivacain zur schmerzbehandlung
MXPA03000313A (es) Uso de fosfato de estramustina en el tratamiento de metastasis osea.
ATE302009T1 (de) Ubichinon qn zur behandlung von migräneschmerzen
ATE377586T1 (de) Tripeptidylpeptidaseinhibitoren
MXPA05010800A (es) Acidos hidroxamicos utiles en el tratamiento de trastornos hiperproliferativos.
ATE236633T1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
PT1003554E (pt) Inibidor da bomba de protoes em combinacao terapeutica com substancias antibacterianas
MXPA04000418A (es) Tratamiento de dolor cronico con 3-heterocicloxi- y -cicloalquiloxi-3-fenilpropanaminas.
DE60128374D1 (de) Varianten des hauptallergen par j 2 von parietaria judaica
NO20062138L (no) Anvendelse av ifenprodil i behandling av smerte

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties